Decorin in Human Colon Cancer: Localization In Vivo and Effect on Cancer Cell Behavior In Vitro |
| |
Authors: | Marie C. Nyman Annele O. Sainio Mirka M. Pennanen Riikka J. Lund Sanna Vuorikoski Jari T. T. Sundstr?m Hannu T. J?rvel?inen |
| |
Affiliation: | Department of Medical Biochemistry and Genetics (MCN, AOS, MMP, HTJ), Department of Pathology (JTTS), and Turku Centre for Biotechnology (RJL, SV), University of Turku, Turku, Finland;Åbo Akademi University, Turku, Finland (RJL, SV);Division of Medicine, Department of Endocrinology, Turku University Hospital, Turku, Finland (HTJ) |
| |
Abstract: | Decorin is generally recognized as a tumor suppressing molecule. Nevertheless, although decorin has been shown to be differentially expressed in malignant tissues, it has often remained unclear whether, in addition to non-malignant stromal cells, cancer cells also express it. Here, we first used two publicly available databases to analyze the current information about decorin expression and immunoreactivity in normal and malignant human colorectal tissue samples. The analyses demonstrated that decorin expression and immunoreactivity may vary in cancer cells of human colorectal tissues. Therefore, we next examined decorin expression in normal, premalignant and malignant human colorectal tissues in more detail using both in situ hybridization and immunohistochemistry for decorin. Our results invariably demonstrate that malignant cells within human colorectal cancer tissues are devoid of both decorin mRNA and immunoreactivity. Identical results were obtained for cells of neuroendocrine tumors of human colon. Using RT-qPCR, we showed that human colon cancer cell lines are also decorin negative, in accordance with the above in vivo results. Finally, we demonstrate that decorin transduction of human colon cancer cell lines causes a significant reduction in their colony forming capability. Thus, strategies to develop decorin-based adjuvant therapies for human colorectal malignancies are highly rational. |
| |
Keywords: | adenoviral transduction antitumorigenic colon cancer decorin neuroendocrine tumor |
|
|